Davanrik was developed to treat depression. However it was later found veto that it also affected the hunger of the person and could be expend as a do medicates for obesity long-sufferings. Davanrik was currently in the pre-clinical development stage when it was offered to Merck to licence it. Since research laboratory was a subaltern company could not afford to get it finished the FDA citation process. LAB offered to give the rights to Merck if pay it an initial tip off rundown lean on each stage and canvass the drug through the entire FDA approval stage, manufacture the drug, marketplace the drug and pay a royalty on every(prenominal) gross revenue to LAB. Clinical Approval Stages In signifier 1, the drug would be administered to 20-80 healthy volunteers to test for safety. The stage would generate 2 years. If Merck opinionated to go ahead with the first sort investment, it would cost $30 jillion including an initial $5 one million million fee to LAB for li censing the drug. Probability of success of stagecoach 1 is 60%.
In Phase 2, a larger number (100-300) of patient volunteers argon tested to determine if the drug is effective or not. Does the recitation of drug have any side cause on patients. It was estimated that there is only 10% prospect that Phase 2 would show that Davanrik would be effective for depression only, 15% probability for weight loss only, and a 5% probability for both(prenominal) depression and weight loss. This phase would also require 2 years and would cost $40 million including a $2.5 million licensing milestone payment to LAB.If you wan t to get a affluent essay, order it on our! website: OrderCustomPaper.com
If you want to get a full essay, visit our page: write my paper